Diabetes: Continuous glucose monitors proven cost-effective, add to quality of life for diabetics

Share this post

A new study based on a 6-month clinical trial, finds that use of a CGM is cost-effective for adult patients with type 1 diabetes when compared to daily use of test strips. The results are well within the thresholds normally used by insurance plans to cover medical devices.

This post was syndicated from Top Health News -- ScienceDaily. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply